FibroBiologics, Inc. (FBLG) Files Proxy Statement Ahead of Shareholder Meeting
Filing Details FibroBiologics, Inc. (NASDAQ:FBLG) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on July 31, 2026. The Healthcare…
Read more
